Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Zai Lab Ltd (9688) Stock Price & Analysis

9688 Stock Chart & Stats

HK$17.37-HK$0.31(-1.75%)
At close: 4:00 PM GMT+8
HKD 15HKD 17.5HKD 203 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
HKD 17.15 - HKD 17.80
52-Week Range
HKD 12.31 - HKD 21.42
Previous Close
HKD 17.68
Volume
1.30M
Average Volume (3M)
4.20M
Market Cap
HKD 21.69B
Enterprise Value
HKD 12.52B
Total Cash (Recent Filing)
HKD 617.52M
Total Debt (Recent Filing)
HKD 254.58M
Price to Earnings (P/E)
―
Beta
1.17
Next Earnings
Nov 05, 2026 (Est.)
EPS Estimate
-0.43
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Gross Margin

A gross margin of approximately 58% indicates that marketed products generate solid product-level economics before operating expenses. If maintained as the portfolio develops, this provides a constructive foundation for improving operating leverage and supporting future investment in commercialization and pipeline development.

Balance Sheet

Moderate leverage and a sizable equity base provide Zai Lab with greater financial flexibility than a highly indebted biotech. This balance-sheet support can help sustain clinical development and commercialization activities while the company works toward improved profitability and reduced reliance on external funding.

Improving Cash Burn

Although cash flow remains negative, the reduction in free cash flow loss represents progress in cash discipline and operating performance. Continued improvement could extend the company’s funding runway and gradually reduce the financial burden of supporting its portfolio and commercial operations.

Bears Say

Revenue Contraction

An approximately 81% TTM revenue decline materially weakens the company’s near-term operating outlook and suggests that prior growth has not yet translated into consistent commercial momentum. Sustained contraction would make it harder to absorb fixed costs and improve profitability over the next several quarters.

Persistent Losses

The deeply negative net margin and ROE show that Zai Lab is not yet converting its business activities and equity base into profits. Persistent losses can constrain reinvestment capacity, delay self-funded growth, and leave earnings dependent on a meaningful improvement in scale or cost efficiency.

Negative Cash Generation

Negative operating and free cash flow indicate that the company continues to consume cash rather than fund operations internally. Even with improving burn, ongoing outflows can pressure balance-sheet capacity and require continued financial support until revenue growth and profitability strengthen.

Zai Lab Ltd News

9688 FAQ

What was Zai Lab Ltd’s price range in the past 12 months?
Zai Lab Ltd lowest stock price was HK$12.31 and its highest was HK$21.42 in the past 12 months.
What is Zai Lab Ltd’s market cap?
Zai Lab Ltd’s market cap is HK$21.69B.
When is Zai Lab Ltd’s upcoming earnings report date?
Zai Lab Ltd’s next earnings report is estimated for Nov 05, 2026 (not yet confirmed), which is in 3 days.
How were Zai Lab Ltd’s earnings last quarter?
Zai Lab Ltd released its earnings results on Aug 06, 2026. The company reported -HK$0.392 earnings per share for the quarter, beating the consensus estimate of -HK$0.545 by HK$0.153.
Is Zai Lab Ltd overvalued?
According to Wall Street analysts Zai Lab Ltd’s price is currently Undervalued.
Does Zai Lab Ltd pay dividends?
Zai Lab Ltd does not currently pay dividends.
What is Zai Lab Ltd’s EPS estimate?
Zai Lab Ltd’s EPS estimate is -0.43.
How many shares outstanding does Zai Lab Ltd have?
Zai Lab Ltd has 1,251,228,000 shares outstanding.
What happened to Zai Lab Ltd’s price movement after its last earnings report?
Zai Lab Ltd reported an EPS of -HK$0.392 in its last earnings report, beating expectations of -HK$0.545. Following the earnings report the stock price went up 0.763%.
Which hedge fund is a major shareholder of Zai Lab Ltd?
Currently, no hedge funds are holding shares in HK:9688
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology